Geftiviq 250mg Tablet 10s

Introduction to Geftiviq 250mg Tablet 10s

Geftiviq 250mg Tablet 10s is a pharmaceutical product in tablet form, primarily used for the treatment of non-small cell lung cancer. This medication is specifically effective for cancers with certain genetic mutations that respond to Gefitinib treatment.

Composition of Geftiviq 250mg Tablet 10s

The active ingredient in Geftiviq 250mg Tablet 10s is Gefitinib, with a concentration of 250mg per tablet. Gefitinib works by inhibiting the epidermal growth factor receptor (EGFR), a protein that promotes the growth and division of cancer cells.

Uses of Geftiviq 250mg Tablet 10s

• Treatment of non-small cell lung cancer
• Effective for cancers with specific genetic mutations

Side effects of Geftiviq 250mg Tablet 10s

• Common side effects: Diarrhea, skin rash, nausea
• Serious side effects: Severe lung problems, liver damage, severe skin reactions

Precautions of Geftiviq 250mg Tablet 10s

Before starting Geftiviq 250mg Tablet 10s, consult your doctor, especially if you have severe liver problems or are pregnant. This medication can cause serious pulmonary and hepatic issues.

How to Take Geftiviq 250mg Tablet 10s

The usual dosage for adults is 250 mg once daily. It is taken orally in tablet form, with or without food, preferably at the same time each day. Follow your doctor's instructions for the correct usage.

Conclusion of Geftiviq 250mg Tablet 10s

Geftiviq 250mg Tablet 10s, containing Gefitinib, is a targeted therapy for non-small cell lung cancer, manufactured by Genoviq Healthcare Pvt Ltd. It is crucial to adhere to medical advice and be aware of potential side effects and precautions. This medication offers a specialized approach to treating specific cancer types, enhancing patient outcomes.